½ÃÀ庸°í¼­
»óǰÄÚµå
1726243

¼¼°èÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® - »ê¾÷º°, ±â¼úº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report By Industry, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 21¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2025-2030³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.43%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇコÄɾî, ȯ°æ, ½Äǰ, ÀǾàǰ µîÀÇ ÃÖÁ¾ ¿ëµµ »ê¾÷Àº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ÀÎÁ¤ ±âÁØÀÇ ´ë»óÀÌ µÇ°í ÀÖÀ¸¸ç, À̰ÍÀÌ ÇâÈÄ ¼ö³â°£ ÀÓ»ó °Ë»ç ±â´É ½ÃÇèÀÇ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±â´É ½ÃÇè ÇÁ·Î±×·¥ Âü°¡ ±â¾÷Àº ½ÃÇè¼Ò°¡ ÀÌ·¯ÇÑ ±âÁØÀ̳ª ±ÔÁ¦ ±â°ü¿¡ ÁذÅÇϰí ÀÖ´Â °ÍÀ» Áõ¸íÇØ, Æò°¡ ÀýÂ÷ÀÇ Á¤È®¼º ¹× ½Å·Ú¼ºÀ» È®º¸Çϴµ¥ µµ¿òÀÌ µÇ°í, ±×¿¡ µû¶ó ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ °øÇåÇÕ´Ï´Ù.

Á¤È®ÇÑ ½ÃÇè ¼­ºñ½º´Â Á¦Ç°ÀÇ Ç°Áú, ¾ÈÀü¼º, °øÁß º¸°Ç¿¡ ÇʼöÀûÀÔ´Ï´Ù. ±â´É½ÃÇèÀ» ÅëÇØ ½ÃÇè¼Ò´Â ±× Æò°¡ °úÁ¤ÀÇ ¸ðµç ´ÜÁ¡À» ÆÄ¾ÇÇÏ°í ´ëóÇÒ ¼ö ÀÖ°Ô µÇ¾î ½Å·Ú¼ºÀÌ ³·Àº µ¥ÀÌÅ͸¦ ÀÛ¼ºÇÒ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 11¿ù µ¶ÀÏ¿¡ °ÅÁ¡À» µÐ KD Pharma Bexbach ǰÁú°ü¸®ÆÀÀº GOED ¿µ¾çº¸Á¶À¯ÀÇ ±ÇÀ§ ÀÖ´Â AOCS ½ÃÇè¼Ò ¼÷·Ãµµ ÇÁ·Î±×·¥¿¡¼­ 1À§ ÀÚ¸®¸¦ È®º¸Çß½À´Ï´Ù. À̰ÍÀº ·¦ Æò°¡¿¡ À־ ¸ð¹üÀûÀÎ ´É·ÂÀ» °­Á¶Çϰí ǰÁú °ü¸®¿Í ¾÷°è Ç¥ÁØ¿¡ ´ëÇÑ ¾à¼ÓÀ» ³ªÅ¸³»´Â °ÍÀÔ´Ï´Ù. ÀÌó·³ PT ¼ö¿ä¸¦ ³ôÀÌ´Â °ÍÀÌ ½ÃÀå ÀüüÀÇ ¼ºÀåÀ¸·Î À̾îÁý´Ï´Ù. Áø´ÜÀ̳ª ±âŸ Á¦Ç°À» Æ÷ÇÔÇÑ ÇコÄÉ¾î ¼­ºñ½º¸¦ Çâ»ó½Ã۱â À§ÇÑ Á¤ºÎÀÇ È£ÀÇÀûÀÎ ´ëó°¡, ´Ù¾çÇÑ ÃÖÁ¾ ¿ëµµ »ê¾÷¿¡¼­ PTÀÇ Ã¤¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, ´ë¸¶ÃÊ ½ÃÇè¼Ò ÀÎÁõ ÇÁ·Î±×·¥(CanNaLAP)°ú °°Àº ½ÃÇè¼ÒÀÇ ½ÇÇà ±âÁØÀº ±â¼ú ½ÃÇèÀÇ Á߿伺À» ±ÔÁ¤ÇÏ°í ½ÃÇè¿¡ »ç¿ëÇØ¾ß ÇÒ »ùÇÃÀÇ À¯Çü°ú °í·ÁÇØ¾ß ÇÒ °á°ú¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀϺΠ´ë¸¶ÃÊ »ý»ê ½Ã¼³Àº ÁÖ Á¤ºÎ°¡ ÀÚÁÖ °Ë»ç¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. American Council of Independent Laboratories(ACIL)¿Í °°Àº Á¶Á÷Àº ¿¬¹æ ±â°ü°ú Çù·ÂÇÏ¿© ´ë¸¶ÃÊ Á¦Ç°ÀÇ Ãë±Þ, »ùÇøµ, ½ÃÇè ¹× °Ë»ç¿¡ ´ëÇÑ Ç¥Áذú ÇÁ·ÎÅäÄÝÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÁøÀÔ±â¾÷Àº ¼¼°è ¹ßÀÚ±¹°ú Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϱâ À§ÇØ ÇùÁ¤, M&A, Á¦ÈÞ, Ãâ½Ã µîÀÇ Àü·«À» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 2¿ù, AOAC´Â Signature Science, LLC¿Í °øµ¿À¸·Î PT ÇÁ·Î±×·¥À» °³¹ßÇÏ¿© »ùÇà Æò°¡¿¡¼­ ǰÁú ¹Ì»ý¹°ÇÐÀÇ ´É·Â¿¡ ´ëÇÑ Çʿ伺À» ÇØ°áÇß½À´Ï´Ù. °Ô´Ù°¡ PCR ¹× Å©·Î¸¶Åä±×·¡ÇÇ¿Í °°Àº ±â¼úÀûÀ¸·Î °íµµÀÇ ½ÃÇèÀ» ½ÃÇè¼ÒÀÇ ±â´É ½ÃÇè¿¡ ä¿ëÇÏ´Â ¿òÁ÷ÀÓÀÌ È°¹ßÇØÁö°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 10¿ù Biogenix Labs´Â ADQCC¿Í Á¦ÈÞÇÏ¿© COVID-19 PCR °Ë»ç¿¡ ƯȭµÈ ±â¼ú ½ÃÇèÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Á¦ÈÞ´Â °Ë»ç ½Ã¼³¿¡ ±â¼ú ½ÃÇè ÇÁ·Î±×·¥À» Á¦°øÇÔÀ¸·Î½á COVID-19 PCR ½ÃÇè °á°úÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» º¸ÀåÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.

ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ºÐ¼® °³¿ä

  • ÀÓ»ó Áø´Ü ºÎ¹®Àº 2024³â 32.73%ÀÇ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. À̰ÍÀº ¿À·ù¸¦ ÃÖ¼ÒÈ­Çϰí Áø´Ü °á°úÀÇ Á¤È®¼º°ú ǰÁúÀ» º¸ÀåÇϱâ À§ÇØ ±â¼ú Å×½ºÆ®(PT)ÀÇ ±¤¹üÀ§ÇÑ Ã¤¿ëÀÌ ¿øµ¿·ÂÀÌ µÇ¾ú½À´Ï´Ù.
  • ¼¼Æ÷ ¹è¾ç ºÎ¹®Àº 2024³â¿¡ 26.82%ÀÇ ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù. ±×°ÍÀÇ Å« ½ÃÀå Á¸Àç´Â °¨¿°¼º ¹Ì»ý¹°ÀÇ °ËÃâ¿¡ ¼¼Æ÷ ¹è¾ç ±â¼úÀÌ ³Î¸® ÀÀ¿ëµÇ°í ÀÖ´Â °ÍÀÌ ÁÖÀÎÀÔ´Ï´Ù.
  • º´¿ø ºÎ¹®Àº 2024³â¿¡ 31.36%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù¸¸, À̰ÍÀº º´¿ø¿¡¼­ Á¤±âÀûÀÎ ´É·Â Æò°¡ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : º¯µ¿ ¿äÀÎ, °æÇâ ¹× ¹üÀ§

  • ½ÃÀåÀÇ ±¸ºÐ ¹× ¹üÀ§
  • ½ÃÀå ¿¬°ü Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã ¹× ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ¼öÁú °Ë»ç¿¡ ´ëÇÑ ÁÖ¸ñ °íÁ¶
    • ÀÇ·á¿ë ´ë¸¶ÀÇ ÇÕ¹ýÈ­ ¹× ´ë¸¶ °Ë»ç ±â°ü Áõ°¡
    • ½ÄÁßµ¶ ¹ß»ý Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ÀÓ»ó °Ë»ç ±â´É ½ÃÇè¿¡ ´ëÇÑ ´Ù¾×ÀÇ ÀÚº»ÅõÀÚ
  • ½ÃÀå µ¿Çâ ¹× Àü¸Á
  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾÷°è ºÐ¼® Åø
    • Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
  • ½ÃÀå ±âȸ ºÐ¼® : ¾÷Á¾º°
    • ÀÓ»ó Áø´Ü
    • ÀǾàǰ
    • ¹Ì»ý¹°ÇÐ
    • ´ë¸¶ÃÊ
    • ±âŸ
  • ½ÃÀåÀÇ »õ·Î¿î Àü·«

Á¦4Àå ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ¾÷Á¾º° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ¾÷Á¾º° º¯µ¿ ºÐ¼®
  • ¾÷Á¾º°
  • ÀÓ»ó Áø´Ü
    • ÀÓ»ó Áø´Ü ½ÃÀå(2018-2030³â)
    • ÀÓ»ó È­ÇÐ
    • ¸é¿ªÈ­ÇÐ
    • Ç÷¾×ÇÐ
    • Á¾¾çÇÐ
    • ºÐÀÚÁø´Ü
    • ÀÀ°í
    • ±âŸ
  • ÀǾàǰ
    • ÀǾàǰ ½ÃÀå(2018-2030³â)
    • »ý¹°Á¦Á¦
    • ±âŸ
  • ¹Ì»ý¹°ÇÐ
    • ¹Ì»ý¹°ÇÐ ½ÃÀå(2018-2030³â)
    • º´¿øÃ¼ °Ë»ç
    • ¹«±Õ½ÃÇè
    • ¿£µµÅå½Å ¹× ¹ß¿­¹°Áú °Ë»ç
    • ¼ºÀå ÃËÁø ½ÃÇè
    • ±âŸ
  • ´ë¸¶ÃÊ
    • ´ë¸¶ ½ÃÀå(2018-2030³â)
    • ÀÇ·á¿ë
    • ºñÀÇ·á¿ë
  • ±âŸ
    • ±âŸ ½ÃÀå(2018-2030³â)

Á¦5Àå ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ±â¼úº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ±â¼úº° º¯µ¿ ºÐ¼®
  • ±â¼úº°
  • ¼¼Æ÷ ¹è¾ç
    • ¼¼Æ÷ ¹è¾ç ½ÃÀå(2018-2030³â)
  • ºÐ±¤ ºÐ¼®
    • ºÐ±¤ ºÐ¼® ½ÃÀå(2018-2030³â)
  • ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
    • ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ½ÃÀå(2018-2030³â)
  • Å©·Î¸¶Åä±×·¡ÇÇ
    • Å©·Î¸¶Åä±×·¡ÇÇ ½ÃÀå(2018-2030³â)
  • ¸é¿ª ÃøÁ¤
    • ¸é¿ª ÃøÁ¤ ½ÃÀå(2018-2030³â)
  • ±âŸ
    • ±âŸ ½ÃÀå(2018-2030³â)

Á¦6Àå ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : ÃÖÁ¾ ¿ëµµº° º¯µ¿ ºÐ¼®
  • ÃÖÁ¾ ¿ëµµº°
  • º´¿ø
    • º´¿ø ½ÃÀå(2018-2030³â)
  • CRO
    • CRO ½ÃÀå(2018-2030³â)
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ ½ÃÀå(2018-2030³â)
  • Çмú¿¬±¸±â°ü
    • Çмú¿¬±¸±â°ü ½ÃÀå(2018-2030³â)
  • °Ë»ç½Ç
    • °Ë»ç½Ç ½ÃÀå(2018-2030³â)
    • µ¶¸³¿¬±¸¼Ò
    • Àü¹® ¿¬±¸¼Ò

Á¦7Àå ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå : Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå Á¡À¯À² : Áö¿ªº°(2024-2030³â)
  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024-2030³â)
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°è Áö¿ª ½ÃÀå ÇöȲ
  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø µ¿Ç⠺м®(2018-2030³â)
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • À¯·´ÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2018-2030³â)
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ű¹
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2018-2030³â)
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • MEAÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ ¹× ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • LGC Limited
    • Bio-Rad Laboratories, Inc
    • Randox Laboratories
    • QACS-The Challenge Test Laboratory
    • Merck KGaA
    • Weqas
    • BIPEA
    • NSI Lab Solutions
    • Absolute Standards, Inc.
    • INSTAND
AJY 25.05.26

Laboratory Proficiency Testing Market Growth & Trends:

The global laboratory proficiency testing market size is estimated to reach USD 2.13 billion by 2030, registering to grow at a CAGR of 6.43% from 2025 to 2030 according to a new report by Grand View Research, Inc. End-use industries, such as healthcare, environmental, food, and pharmaceuticals, are subject to strict regulatory requirements and accreditation standards, which is anticipated to drive the demand for laboratory proficiency testing in the coming years. Moreover, participating in proficiency testing programs helps laboratories demonstrate compliance with these standards and regulatory bodies, ensuring the accuracy and reliability of their evaluating procedures, thereby contributing to the growth of the overall market.

Accurate test service is vital for product quality, safety, and public health. Proficiency testing enables laboratories to identify and address any shortcomings in their evaluating processes, reducing the risk of producing unreliable data. For instance, in November 2022, KD Pharma Bexbach's Quality Control team based in Germany secured the top position in the prestigious AOCS Laboratory Proficiency Program for GOED Nutraceutical Oils. This highlights its exemplarycompetence in laboratory evaluation, showcasing its commitment to quality control and industry standards. Thus, making PT more demandable leads to overall market growth. Favorable government initiatives to improve healthcare services, including diagnostics and other products, are increasing the adoption of PT in different end-use industries.

For instance, laboratory standards of practice, such as the Cannabis Laboratory Accreditation Program (CanNaLAP), specify the importance of proficiency testing and provide information regarding the types of samples that should be used for testing and the results that should be considered. Furthermore, several cannabis production facilities are frequently inspected by state governments. Organizations, such as the American Council of Independent Laboratories (ACIL), collaborate with federal agencies to develop standards & protocols for handling, sampling, testing, and inspecting cannabis products. The key participants are engaged in strategies, such as agreements, mergers & acquisitions, partnerships, and launches, to expand their global footprints and product portfolio.

For instance,in February 2023, AOAC collaborated with Signature Science, LLC, to develop a PT program that addresses the need for quality microbiology competence in evaluating samples. Moreover, the increasing adoption of technologically advanced tests, such as PCR and chromatography for laboratory proficiency tests is further supporting the market growth. For instance, in October 2021, Biogenix Labs partnered with ADQCC to offer proficiency testing specifically for COVID-19 PCR tests. This collaboration aims to ensure the accuracy and reliability of COVID-19 PCR test results by providing laboratories with proficiency testing programs.

Laboratory Proficiency Testing Market Report Highlights:

  • The clinical diagnostics segment accounted for the largest market share of 32.73% in 2024, driven by the widespread adoption of proficiency testing (PT) to minimize errors and ensure the accuracy and quality of diagnostic results.
  • The cell culture segment led the market with a 26.82% revenue share in 2024. Its substantial market presence is largely due to the widespread application of cell culture techniques for detecting infectious microorganisms.
  • The hospital segment dominated the market with a revenue share of 31.36% in 2024, owing to the increasing need for regular competence evaluation in hospitals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Industry
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Industry outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Laboratory Proficincy Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Focus on Water Testing
    • 3.4.2. Legalization of Medical Cannabis and Growing Number of Cannabis Testing Laboratories
    • 3.4.3. Increase in Outbreaks of Foodborne Illnesses
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Capital Investment for Laboratory Proficiency Testing
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
  • 3.7. Market Opportunity Analysis, by Industry
    • 3.7.1. Clinical Diagnostics
    • 3.7.2. Pharmaceuticals
    • 3.7.3. Microbiology
    • 3.7.4. Cannabis
    • 3.7.5. Others
  • 3.8. Market Emerging Statergies

Chapter 4. Laboratory Proficincy Testing Market: Industry Estimates & Trend Analysis

  • 4.1. Laboratory Proficiency Testing Market: Industry Movement Analysis
  • 4.2. Laboratory Proficiency Testing Market Estimates and Forecast, by Industry
  • 4.3. Clinical Diagnostics
    • 4.3.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.2. Clinical Chemistry
      • 4.3.2.1. Clinical Chemistry Market, 2018 - 2030 (USD Million)
    • 4.3.3. Immunochemistry
      • 4.3.3.1. Immunochemistry Market, 2018 - 2030 (USD Million)
    • 4.3.4. Hematology
      • 4.3.4.1. Hematology Market, 2018 - 2030 (USD Million)
    • 4.3.5. Oncology
      • 4.3.5.1. Oncology Market, 2018 - 2030 (USD Million)
    • 4.3.6. Molecular Diagnostics
      • 4.3.6.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
      • 4.3.6.2. PCR
        • 4.3.6.2.1. PCR Market, 2018 - 2030 (USD Million)
      • 4.3.6.3. Others
        • 4.3.6.3.1. Othes Market, 2018 - 2030 (USD Million)
    • 4.3.7. Coagulation
      • 4.3.7.1. Coagulation Market, 2018 - 2030 (USD Million)
    • 4.3.8. Others
      • 4.3.8.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Pharmaceuticals
    • 4.4.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
    • 4.4.2. Biological Products
      • 4.4.2.1. Biological Products Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. Vaccines
        • 4.4.2.2.1. Vaccines Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Blood
        • 4.4.2.3.1. Blood Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Tissues
        • 4.4.2.4.1. Tissues Market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Microbiology
    • 4.5.1. Microbiology Market, 2018 - 2030 (USD Million)
    • 4.5.2. Pathogen Testing
      • 4.5.2.1. Pathogen Testing Market, 2018 - 2030 (USD Million)
    • 4.5.3. Sterility Testing
      • 4.5.3.1. Sterility Testing Market, 2018 - 2030 (USD Million)
    • 4.5.4. Endotoxin & Pyrogen Testing
      • 4.5.4.1. Endotoxin & Pyrogen Testing Market, 2018 - 2030 (USD Million)
    • 4.5.5. Growth Promotion Testing
      • 4.5.5.1. Growth Promotion Testing Market, 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.6. Cannabis
    • 4.6.1. Cannabis Market, 2018 - 2030 (USD Million)
    • 4.6.2. Medical
      • 4.6.2.1. Medical Market, 2018 - 2030 (USD Million)
    • 4.6.3. Non-Medical
      • 4.6.3.1. Non-Medical Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Laboratory Proficincy Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Laboratory Proficiency Testing Market: Technology Movement Analysis
  • 5.2. Laboratory Proficiency Testing Market Estimates and Forecast, by Technology
  • 5.3. Cell Culture
    • 5.3.1. Cell Culture Market, 2018 - 2030 (USD Million)
  • 5.4. Spectrometry
    • 5.4.1. Spectrometry Market, 2018 - 2030 (USD Million)
  • 5.5. Polymerase Chain Reaction
    • 5.5.1. Polymerase Chain Reaction Market, 2018 - 2030 (USD Million)
  • 5.6. Chromatography
    • 5.6.1. Chromatography Market, 2018 - 2030 (USD Million)
  • 5.7. Immunoassays
    • 5.7.1. Immunoassays Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Laboratory Proficincy Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Laboratory Proficiency Testing Market: End-use Movement Analysis
  • 6.2. Laboratory Proficiency Testing Market Estimates and Forecast, by End Use
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.4. Contract Research Organizations
    • 6.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.7. Laboratories
    • 6.7.1. Laboratories Market, 2018 - 2030 (USD Million)
    • 6.7.2. Independent Laboratories
      • 6.7.2.1. Independent Laboratories Market, 2018 - 2030 (USD Million)
    • 6.7.3. Specialty Laboratories
      • 6.7.3.1. Specialty Laboratories Market, 2018 - 2030 (USD Million)

Chapter 7. Laboratory Proficincy Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Laboratory Proficiency Testing Market Share By Region, 2024 & 2030
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Regional Market Dashboard
  • 7.4. Global Regional Market Snapshot
  • 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. North America Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. U.S. Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.6.3. Canada
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Canada Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.6.4. Mexico
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Mexico Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
  • 7.7. Europe
    • 7.7.1. Europe Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.2. UK
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. UK Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.3. Germany
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Germany Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.4. France
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. France Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.5. Italy
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Italy Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.6. Spain
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Spain Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.7. Denmark
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Denmark Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.8. Sweden
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Sweden Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.7.9. Norway
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Norway Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
  • 7.8. Asia Pacific
    • 7.8.1. Asia Pacific Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.2. Japan
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Japan Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.3. China
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. China Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.4. India
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. India Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.5. Australia
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Australia Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.6. Thailand
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Competitive Scenario
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Thailand Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.8.7. South Korea
      • 7.8.7.1. Key Country Dynamics
      • 7.8.7.2. Competitive Scenario
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. South Korea Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
  • 7.9. Latin America
    • 7.9.1. Latin America Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.9.2. Brazil
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Brazil Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.9.3. Argentina
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Argentina Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
  • 7.10. MEA
    • 7.10.1. MEA Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.10.2. South Africa
      • 7.10.2.1. Key Country Dynamics
      • 7.10.2.2. Competitive Scenario
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. South Africa Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.10.3. Saudi Arabia
      • 7.10.3.1. Key Country Dynamics
      • 7.10.3.2. Competitive Scenario
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Saudi Arabia Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.10.4. UAE
      • 7.10.4.1. Key Country Dynamics
      • 7.10.4.2. Competitive Scenario
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. UAE Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)
    • 7.10.5. Kuwait
      • 7.10.5.1. Key Country Dynamics
      • 7.10.5.2. Competitive Scenario
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Kuwait Laboratory Proficiency Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Strategy Mapping
  • 8.4. Company Market Share Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. LGC Limited
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bio-Rad Laboratories, Inc
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Randox Laboratories
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. QACS - The Challenge Test Laboratory
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Merck KGaA
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Weqas
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. BIPEA
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. NSI Lab Solutions
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Absolute Standards, Inc.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. INSTAND
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦